STOCK TITAN

Benson Hill Announces Full Year 2022 Financial Results and Expectations for Strong Proprietary Product Growth in 2023

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Benson Hill, Inc. (NYSE: BHIL) reported a remarkable 319% revenue increase to $381 million for 2022, with proprietary revenues nearly doubling to $73 million. Gross profit stood at $3.5 million, impacted by a $4.9 million loss from mark-to-market timing differences. The company anticipates proprietary revenues to grow to $100-$110 million in 2023, driving gross profit to $20-$30 million. Despite a projected net loss of $125-$135 million in 2023 and further capital expenditures, management remains committed to achieving positive Adjusted EBITDA by 2025, supported by strategic investments in high-margin products.

Positive
  • Revenue increased by 319% to $381 million.
  • Proprietary revenues nearly doubled to $73 million.
  • Expected proprietary revenue growth to $100-$110 million in 2023.
  • Projected gross profit increase to $20-$30 million in 2023.
  • Plans to retire $100 million high-cost debt early.
Negative
  • Net loss from continuing operations was $99.7 million.
  • Adjusted EBITDA loss expected between $63 million to $68 million.
  • Free cash flow loss expected in 2023 between $120 million to $128 million.
  • Higher operating expenses, totaling $128.5 million.
  • Revenues increased 319 percent to $381 million, including a near doubling of proprietary revenues to $73 million.
  • Gross profit was $3.5 million ($8.5 million when excluding an approximate $4.9 million loss from open mark-to-market timing differences).
  • 2023 proprietary revenues are expected to grow to an estimated range of $100 million to $110 million and help drive a more than doubling of gross profit in the range of $20 million to $30 million.
  • 2023 Adjusted EBITDA loss is expected to narrow and use of free cash is expected to increase due primarily to planned investments to enable additional, higher margin food-grade manufacturing capabilities.
  • In 2025, management remains committed to the target of positive Adjusted EBITDA and free cash flow as it focuses on the highest-margin proprietary products in response to persistent high costs across the supply chain.
  • The Company expects to execute a plan to optimize its capital structure and actions to increase return on capital.

ST. LOUIS--(BUSINESS WIRE)-- Benson Hill, Inc. (NYSE: BHIL, the “Company” or “Benson Hill”), a food tech company unlocking the natural genetic diversity of plants, today announced operating and financial results for the year ended December 31, 2022.

Benson Hill, Inc., a food tech company unlocking the natural genetic diversity of plants, today announced operating and financial results for the year ended December 31, 2022. (Graphic: Business Wire)

Benson Hill, Inc., a food tech company unlocking the natural genetic diversity of plants, today announced operating and financial results for the year ended December 31, 2022. (Graphic: Business Wire)

“2022 was an exceptional year for Benson Hill, and we expect 2023 to bring continued proprietary revenue growth and gross margin expansion led by our soy ingredient products,” said Matt Crisp, Chief Executive Officer of Benson Hill. “Demand for our innovations remains strong, although persistent high supply chain costs are impacting our profitability in certain food ingredient categories, which we believe will continue for the foreseeable future. To meet the needs of our customers, we will execute a more targeted growth strategy focused on the highest-margin proprietary products and one that de-emphasizes lower margin products. In addition, we are finalizing and expect to implement capital management changes designed to reduce debt, interest and operating expenses, and increase return on capital, while maintaining our commitment to fully fund the business. Our team demonstrated its ability to meet our strategic objectives, and we remain steadfast in our commitment to shareholders to achieve significant yet disciplined growth, as well as our target of profitability in 2025.”

Full Year 2022 Results as Compared to The Same Period of 2021

The financial results discussed in this press release exclude the Fresh business, which was divested in a two-part transaction announced on January 3, 2023, the initial portion of which was consummated on December 29, 2022, and the second portion of which is expected to close in the second quarter of 2023. The Company recorded the Fresh business as discontinued operations as of December 31, 2022. The impact of open mark-to-market timing differences on the profit and loss statement and reconciliation of non-GAAP financial measures can be found on pages 6 and 12, respectively.

  • Revenues were $381.2 million, an increase of $290.3 million, or 319 percent. Strong demand from customers and greater availability of proprietary soy ingredients, meal and edible oil products resulted in a near doubling of proprietary revenues to $72.6 million. Non-proprietary revenues increased significantly due to favorable soy and yellow pea commodity prices and operational excellence associated with the startup of two soy production facilities.
  • Gross profit was $3.5 million, an increase of $9.4 million. Excluding approximately $4.9 million in losses due to open mark-to-market timing differences, gross profit was $8.5 million and gross margins were 2.2 percent. Favorable top line growth, proprietary revenue mix, and contributions from partnership and licensing agreements were partially offset by cost pressures in the supply chain as well as the impact from adverse weather in the month of December.
  • Operating expenses were $128.5 million, a $16.0 million increase, which includes $34.0 million for non-cash items primarily related to stock compensation and depreciation.
    • Selling, general and administrative expenses were $81.0 million, an increase of $9.1 million or 13 percent.
    • R&D expenses were $47.5 million, an increase of $6.9 million or 17 percent.
    • All year-over-year operating expense increases were related to non-cash items.
  • Inclusive of open mark-to-market timing differences, net loss from continuing operations was $99.7 million, a decrease in loss of $22.5 million or 18 percent. Adjusted EBITDA was a loss of $81.6 million, or a loss of $76.7 million, excluding the impact from open mark-to-market timing differences, which was in line with the prior year.
  • Cash, restricted cash, and marketable securities of $175.0 million were on hand as of December 31, 2022.

Fourth Quarter 2022 Results as Compared to The Same Period of 2021

  • Revenues were $99.2 million, an increase of $68.4 million, or 223 percent. The performance was driven by sales for both proprietary and non-proprietary soy and yellow pea products.
  • Gross profit was $0.8 million, an increase in profitability of $4.0 million, and includes an approximately $3.3 million loss due to open mark-to-market timing difference. Gross margins were approximately 4 percent when excluding open mark-to-market timing differences.
  • Inclusive of mark-to-market timing differences, net loss from continuing operations was $30.8 million, a decrease in loss of $10.4 million or 25.3 percent. Adjusted EBITDA was a loss of $21.4 million compared to a loss of $29.1 million.

Outlook

Excludes the Fresh segment which is now classified as discontinued operations.

Management expects continued strong demand for its proprietary products in 2023 resulting in a 40 percent to 50 percent increase in proprietary revenues to a range of $100 million to $110 million. Non-proprietary revenues are expected to decline moderately in favor of proprietary products, which sets the expectation for consolidated revenues to be in the range of $390 million to $430 million.

Consolidated gross profit is expected to be in the range of $20 million to $30 million driven by anticipated increases in proprietary sales, increased revenues from partnership and licensing agreements, which is expected to have higher margins, and favorable soy commodity markets for non-proprietary product sales. This outlook includes assumptions for persistent inflationary and supply chain logistics.

The Company expects a net loss of $125 million to $135 million and Adjusted EBITDA loss in the range of $63 million to $68 million.

Capital expenditures are expected to be in the range of $20 million to $25 million due to a two-year capital project to add the capability for soy flour texturization at the Creston, Iowa facility.

Management is in the advanced stages of finalizing a plan designed to lower the cost of capital, increase return on capital, and reduce costs. During the back half of this year, the Company expects to retire the existing $100 million high-cost debt two years early and replace it with a conventional, lower cost lending facility. The Company intends to utilize its current shelf registration statement, including its ATM facility, or alternative equity financing, for up to $100 million to supplement the cash needed to fully fund the business to profitability in 2025. The anticipated retirement of the existing debt will incur pre-payment penalties and other costs that, along with the planned capital expenditures, is expected to result in a free cash flow loss in 2023 of $120 million to $128 million. Management is also exploring strategic options for its Seymour, Indiana, soy crush facility to deploy capital more effectively within the closed-loop operations, reduce costs, and increase return on capital.

Management remains committed to its objective of achieving positive Adjusted EBITDA and positive free cash flow in 2025. The adoption of the targeted growth strategy is expected to result in proprietary revenues in 2025 of at least $300 million compared to the prior target of over $350 million. Consolidated revenues are forecasted to be $400 million or greater. The target for gross margins remains at 25 percent.

Webcast

A webcast of the conference call will begin at 8:30 a.m. ET today. The link to participate is available on the Investor Relations page of the Company’s website.

About Benson Hill

Benson Hill moves food forward with the CropOS® platform, a cutting-edge food innovation engine that combines data science and machine learning with biology and genetics. Benson Hill empowers innovators to unlock nature’s genetic diversity from plant to plate, with the purpose of creating nutritious, great-tasting food and ingredient options that are both widely accessible and sustainable. More information can be found at bensonhill.com or on Twitter at @bensonhillinc.

Use of Non-GAAP Financial Measures

In this press release, the Company includes references to non-GAAP performance measures. The Company uses these non-GAAP financial measures to facilitate management’s financial and operational decision-making, including evaluation of the Company’s historical operating results. The Company’s management believes these non-GAAP measures are useful in evaluating the Company’s operating performance and are similar measures reported by publicly listed U.S. competitors, and regularly used by securities analysts, institutional investors, and other interested parties in analyzing operating performance and prospects. These non-GAAP financial measures reflect an additional way of viewing aspects of the Company’s operations that, when viewed with GAAP results and the reconciliations to corresponding GAAP financial measures, may provide a more complete understanding of factors and trends affecting the Company’s business. By referencing these non-GAAP measures, the Company’s management intends to provide investors with a meaningful, consistent comparison of the Company’s performance for the periods presented. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP. The Company’s definition of these non-GAAP measures may differ from similarly titled measures of performance used by other companies in other industries or within the same industry. Because non-GAAP financial measures exclude the effect of items that will increase or decrease the Company’s reported results of operations, management strongly encourages investors to review the Company’s consolidated financial statements and publicly filed reports in their entirety.

Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the tables accompanying this press release.

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this press release may be considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or the Company’s future financial or operating performance and may be identified by words such as “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” or similar words. These forward-looking statements are based upon assumptions made by the Company as of the date hereof and are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements include, among other things, statements regarding the Company’s plans to improve its capital structure; the Company’s current guidance regarding certain expected 2023 financial and operating results, including guidance regarding consolidated, proprietary and non-proprietary revenues and revenues from partnership and licensing agreements, margins, consolidated gross profit, net loss, Adjusted EBITDA, capital expenditures and use of free cash flow; expectations regarding actions intended to lower the cost of capital, increase return on capital, and reduce costs, including plans to retire its existing debt early and replace it with a conventional lending facility, including expectations regarding pre-payment penalties and other costs in connection therewith, plans regarding equity financing to supplement the cash needed to fully fund the business to profitability in 2025, and statements regarding the Company’s plans to explore strategic options for its Seymour, Indiana, soy crush facility; any statements regarding the Company’s plans to fully fund the business to profitability in 2025; expectations regarding macro-economic trends; expectations regarding the sources of expected consolidated revenue and gross profit growth, including improved commodity market conditions for non-proprietary product sales, and enhanced focus on higher margin product categories; expectations regarding revenue and gross profit mix; expectations regarding future costs and uses of free cash flow; expectations regarding the unwinding of mark-to-market timing differences and the Company’s assessment of its futures contracts; the expected timing and anticipated benefits of the divestiture of the Fresh business, including the consummation of the pending transaction pertaining to the Fresh assets remaining to be sold; any financial or other information based upon or otherwise incorporating judgments or estimates relating to future performance, events or expectations; expectations regarding the Company’s hedging and other risk management strategies, including expectations about future sales and purchases that relate to the Company’s mark-to-market adjustments and the fair valuation of futures contracts; the Company’s strategies, positioning, resources, capabilities, and expectations for future performance; estimates and forecasts of financial and other performance metrics; projections of market opportunity and supply chain constraints; the Company’s outlook and financial and other guidance; management’s strategy and plans for growth, including those intended to lower the cost of capital, increase return on capital and reduce costs. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: risks associated with the Company’s inability to execute on its plans to lower the cost of capital, increase return on capital and reduce costs; the risk that the Company’s actions intended to fully fund the business to profitability in 2025 will be insufficient to achieve such objective; risks associated with the Company’s ability to grow and achieve growth profitably, including continued access to the capital resources necessary for growth; the risk that the Company will be unable to renegotiate or retire any of its existing debt by entering into an amended or new facility in a timely manner, on favorable terms, or at all; risks relating to the failure to realize the anticipated benefits of the Company’s shelf registration statement, including its at-the-market facility, or otherwise fail to raise equity capital to supplement its cash needs; risks relating to potential dilution; risks relating to the Company’s hedging and other risk management strategies, including expectations about future sales and purchases that relate to the Company’s mark-to-market adjustments and the fair valuation of futures contracts; the risk that the Company will not realize the anticipated benefits of the divestiture of the Fresh business, including risks relating to the failure to satisfy the conditions to the consummation of the pending transaction to sell the remaining assets of the Fresh business, and the risk that such transaction may not be completed in a timely manner or at all; risks associated with managing capital resources; risks associated with maintaining relationships with customers and suppliers and developing and maintaining partnering and licensing relationships; risks associated with changing industry conditions and consumer preferences; risks associated with the Company’s ability to generally execute on its business strategy; risks associated with the effects of global and regional economic, agricultural, financial and commodities market, political, social and health conditions; risks associated with the Company’s transition to becoming a public company; the effectiveness of the Company’s risk management strategies; and other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in our filings with the SEC, which are available on the SEC’s website at www.sec.gov. The Company can make no assurances that it will be able to retire its existing debt early on the anticipated timeframe, or at all, or that it will be able to replace such debt with a conventional, lower cost, lending facility, or any facility, on favorable terms, in a timely manner, or at all. Similarly, the Company can make no assurances that it will be able to raise up to $100 million, or any amount, of equity financing, whether under the Company’s shelf registration statement, including its ATM facility, or otherwise. Forward-looking statements are also subject to the risks and other issues described above under “Use of Non-GAAP Financial Measures,” which could cause actual results to differ materially from current expectations included in the Company’s forward-looking statements included in this press release. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward looking statements will be achieved, including without limitation, any expectations about our operational and financial performance or achievements through and including 2025. There may be additional risks about which the Company is presently unaware or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Company expressly disclaim any duty to update these forward-looking statements, except as otherwise required by law.

Benson Hill, Inc.
Material Items Included in Consolidated Revenues and Cost of Sales
(In Thousands)

Currently, the Company does not seek cash flow hedge accounting treatment for its derivative financial instruments and thus changes in fair value are reflected in current earnings.

Mark-to-market timing difference comprises the estimated net temporary impact resulting from unrealized period-end gains/losses associated with the fair valuation of futures contracts associated with the Company’s committed future operating capacity. These mark-to-market timing differences are not indicative of the Company’s operating performance.

The Company recorded the fair value of acquired sales and purchase contracts in the acquisition of the Company’s Creston, Iowa location, which are amortized, not marked-to-market, to revenues and cost of sales to the physical contracts.

The table below summarizes the pre-tax gains and losses related to derivatives and contract assets and liabilities:

 

Fiscal Year 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Open Mark-to-Market Timing Differences

2022
Reported
(unaudited)

 

Q1
Impact

 

Q2
Impact

 

Q3
Impact

 

Q4
Impact

 

2022
Excluding
Impact

Revenues

$

381,233

 

 

$

(5,002

)

 

$

3,885

 

$

3,267

 

$

(4,534

)

 

$

383,617

 

Gross profit

$

3,527

 

 

$

(8,181

)

 

$

5,227

 

$

1,381

 

$

(3,353

)

 

$

8,453

 

Total operating expenses

$

128,534

 

 

$

 

 

$

 

$

 

$

 

 

$

128,534

 

Net loss from continuing operations

$

(99,700

)

 

$

(8,181

)

 

$

5,227

 

$

1,381

 

$

(3,353

)

 

$

(94,774

)

Adjusted EBITDA

$

(81,645

)

 

$

(8,181

)

 

$

5,227

 

$

1,381

 

$

(3,353

)

 

$

(76,719

)

  • 2022: The net temporary unrealized period-end loss on revenues and cost of sales was $2.4 million and $4.9 million, respectively. Management expects the open mark-to-market timing differences to unwind in the coming months.
  • See Adjusted EBITDA reconciliation on page 12.
   

Benson Hill, Inc.

Consolidated Balance Sheets (Unaudited)

(In Thousands)

   

December 31,

2022

 

2021

Assets

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

25,053

 

 

$

78,940

 

Marketable securities

 

132,121

 

 

 

103,689

 

Accounts receivable, net

 

28,591

 

 

 

22,128

 

Inventories, net

 

62,110

 

 

 

37,004

 

Prepaid expenses and other current assets

 

29,346

 

 

 

16,806

 

Current assets held for sale

 

23,507

 

 

 

24,791

 

Total current assets

 

300,728

 

 

 

283,358

 

Property and equipment, net

 

99,759

 

 

 

98,076

 

Right of use asset, net

 

68,193

 

 

 

73,712

 

Goodwill and intangible assets, net

 

27,377

 

 

 

35,397

 

Other assets

 

4,863

 

 

 

4,538

 

Noncurrent assets held for sale

 

 

 

 

39,816

 

Total assets

$

500,920

 

 

$

534,897

 

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$

36,717

 

 

$

20,288

 

Current lease liability

 

3,682

 

 

 

1,831

 

Current maturities of long-term debt

 

2,242

 

 

 

6,901

 

Accrued expenses and other liabilities

 

33,435

 

 

 

25,608

 

Current liabilities held for sale

 

16,441

 

 

 

17,054

 

Total current liabilities

 

92,517

 

 

 

71,682

 

Long-term debt

 

103,991

 

 

 

77,035

 

Long-term lease liability

 

77,722

 

 

 

77,152

 

Warrant liabilities

 

24,285

 

 

 

46,051

 

Conversion option liability

 

8,091

 

 

 

8,783

 

Deferred tax liabilities

 

283

 

 

 

294

 

Other non-current liabilities

 

129

 

 

 

316

 

Noncurrent liabilities held for sale

 

 

 

 

2,137

 

Total liabilities

 

307,018

 

 

 

283,450

 

Stockholders’ equity:

 

 

 

Redeemable convertible preferred stock, $0.0001 par value; 1,000 authorized, no shares issued and outstanding as of December 31, 2022 and 2021, respectively

 

 

 

 

 

Common stock, $0.0001 par value, 440,000 and 440,000 shares authorized; 206,668 and 178,089 shares issued and outstanding as of December 31, 2022 and 2021, respectively

 

21

 

 

 

18

 

Additional paid-in capital

 

609,450

 

 

 

533,101

 

Accumulated deficit

 

(408,474

)

 

 

(280,569

)

Accumulated other comprehensive loss

 

(7,095

)

 

 

(1,103

)

Total stockholders’ equity

 

193,902

 

 

 

251,447

 

Total liabilities and stockholders’ equity

$

500,920

 

 

$

534,897

 

 

Benson Hill, Inc.

Consolidated Statements of Operations (Unaudited)

(In Thousands, Except Per Share Information)

 

Three Months Ended December 31,

 

Year Ended December 31,

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

Revenues

$

99,180

 

 

$

30,732

 

 

$

381,233

 

 

$

90,945

 

Cost of sales

 

98,391

 

 

 

33,972

 

 

 

377,706

 

 

 

96,846

 

Gross profit (loss)

 

789

 

 

 

(3,240

)

 

 

3,527

 

 

 

(5,901

)

Operating expenses:

 

 

 

 

 

 

 

Research and development

 

11,761

 

 

 

14,171

 

 

 

47,500

 

 

 

40,574

 

Selling, general and administrative expenses

 

21,586

 

 

 

21,534

 

 

 

81,034

 

 

 

71,947

 

Total operating expenses

 

33,347

 

 

 

35,705

 

 

 

128,534

 

 

 

112,521

 

Loss from operations

 

(32,558

)

 

 

(38,945

)

 

 

(125,007

)

 

 

(118,422

)

Other (income) expense:

 

 

 

 

 

 

 

Interest expense, net

 

5,414

 

 

 

611

 

 

 

21,444

 

 

 

4,481

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

11,742

 

Change in fair value of warrants and conversion

 

(7,387

)

 

 

398

 

 

 

(49,063

)

 

 

(12,127

)

Other (income) expense, net

 

149

 

 

 

1,226

 

 

 

2,253

 

 

 

(549

)

Total other (income) expense, net

 

(1,824

)

 

 

2,235

 

 

 

(25,366

)

 

 

3,547

 

Net loss from continuing operations before income tax

 

(30,734

)

 

 

(41,180

)

 

 

(99,641

)

 

 

(121,969

)

Income tax expense

 

29

 

 

 

13

 

 

 

59

 

 

 

231

 

Net loss from continuing operations, net of tax

 

(30,763

)

 

 

(41,193

)

 

 

(99,700

)

 

 

(122,200

)

Net loss from discontinued operations, net of tax

 

(22,843

)

 

 

(1,014

)

 

 

(28,205

)

 

 

(4,047

)

Net loss

$

(53,606

)

 

$

(42,207

)

 

$

(127,905

)

 

$

(126,247

)

 

 

 

 

 

 

 

 

Net loss per common share:

 

 

 

 

 

 

 

Basic and diluted net loss per common share from continuing operations

$

(0.17

)

 

$

(0.26

)

 

$

(0.55

)

 

$

(1.00

)

Basic and diluted net loss from discontinued operations, net of tax

$

(0.12

)

 

$

(0.01

)

 

$

(0.16

)

 

$

(0.04

)

Basic and diluted net loss per common share

$

(0.29

)

 

$

(0.27

)

 

$

(0.71

)

 

$

(1.04

)

Weighted average shares outstanding:

 

 

 

 

 

 

 

Basic and diluted weighted average shares outstanding

 

186,787

 

 

 

158,323

 

 

 

179,867

 

 

 

121,838

 

 

 

 

 

 

 

 

 

 

Benson Hill, Inc.

Consolidated Statements of Comprehensive Loss (Unaudited)

(In Thousands)

 

Three Months Ended December 31,

 

Year Ended December 31,

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

Net loss

$

(53,606

)

 

$

(42,207

)

 

$

(127,905

)

 

$

(126,247

)

Foreign currency:

 

 

 

 

 

 

 

Comprehensive (loss) income

 

37

 

 

 

(26

)

 

 

(9

)

 

 

4

 

 

37

 

 

 

(26

)

 

 

(9

)

 

 

4

 

Marketable securities:

 

 

 

 

 

 

 

Comprehensive loss

 

6,240

 

 

 

(1,963

)

 

 

(3,678

)

 

 

(1,813

)

Adjustments for net (losses) income realized in net loss

 

(4,437

)

 

 

1,234

 

 

 

(2,305

)

 

 

1,031

 

 

1,803

 

 

 

(729

)

 

 

(5,983

)

 

 

(782

)

Total other comprehensive (loss) income

 

1,840

 

 

 

(755

)

 

 

(5,992

)

 

 

(778

)

Total comprehensive loss

$

(51,766

)

 

$

(42,962

)

 

$

(133,897

)

 

$

(127,025

)

 

Benson Hill, Inc.

Consolidated Statements of Cash Flows (Unaudited)

(In Thousands)

 

Year Ended December 31,

 

2022

 

 

 

2021

 

Operating activities

 

Net loss

$

(127,905

)

 

$

(126,247

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

22,836

 

 

 

12,817

 

Stock-based compensation expense

 

19,520

 

 

 

7,183

 

Bad debt expense

 

863

 

 

 

309

 

Change in fair value of warrants and conversion options

 

(49,063

)

 

 

(12,127

)

Amortization related to financing activities

 

9,279

 

 

 

1,389

 

Loss on extinguishment of debt

 

 

 

 

11,742

 

Loss on divestiture of discontinued operations

 

10,246

 

 

 

 

Impairment

 

11,579

 

 

 

 

Loss on investments and amortization on premiums

 

4,755

 

 

 

 

Other

 

4,579

 

 

 

(65

)

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

(3,070

)

 

 

(7,038

)

Inventories

 

(4,663

)

 

 

(11,690

)

Other assets

 

6,542

 

 

 

(13,149

)

Accounts payable

 

(5,313

)

 

 

11,293

 

Accrued expenses

 

6,419

 

 

 

7,539

 

Other liabilities

 

 

 

 

294

 

Net cash used in operating activities

 

(93,396

)

 

 

(117,750

)

Investing activities

 

 

 

Purchases of marketable securities

 

(372,170

)

 

 

(648,923

)

Proceeds from maturities of marketable securities

 

139,063

 

 

 

2,499

 

Proceeds from sales of marketable securities

 

193,250

 

 

 

639,612

 

Payments for acquisitions of property and equipment

 

(16,486

)

 

 

(31,490

)

Payments made in connection with business acquisitions

 

(1,034

)

 

 

(116,287

)

Proceeds from divestitures of discontinued operations

 

17,131

 

 

 

 

Net cash used in investing activities

 

(40,246

)

 

 

(154,589

)

Financing activities

 

 

 

Net contributions from Merger, at-the-market offering and PIPE financing, net of transaction costs of $4,087 and $34,940 for 2022 and 2021, respectively

 

81,109

 

 

 

285,378

 

Payments for extinguishment of debt

 

 

 

 

(43,082

)

Principal payments on debt

 

(7,288

)

 

 

(4,400

)

Proceeds from issuance of debt

 

23,540

 

 

 

103,634

 

Borrowing under revolving line of credit

 

19,774

 

 

 

20,954

 

Repayments under revolving line of credit

 

(19,821

)

 

 

(20,907

)

Proceeds from issuance of redeemable convertible preferred stock, net of costs

 

 

 

 

 

Retirement of redeemable convertible preferred stock

 

 

 

 

 

Repayments of financing lease obligations

 

(1,630

)

 

 

(703

)

Proceeds from the exercise of stock options and warrants

 

2,325

 

 

 

681

 

Net cash provided by financing activities

 

98,009

 

 

 

341,555

 

Effect of exchange rate changes on cash

 

(9

)

 

 

4

 

Net increase (decrease) in cash, cash equivalents and restricted cash

 

(35,642

)

 

 

69,220

 

Cash, cash equivalents and restricted cash, beginning of year

 

78,963

 

 

 

9,743

 

Cash, cash equivalents and restricted cash, end of year

$

43,321

 

 

$

78,963

 

Supplemental disclosure of cash flow information

 

 

 

 

 

Cash paid for taxes

$

57

 

 

$

53

 

Cash paid for interest

$

14,398

 

 

$

6,591

 

Supplemental disclosure of non-cash activities

 

 

 

 

 

Issuance of Notes Payable Warrants and Convertible Notes Payable Warrants

$

 

 

$

6,663

 

Conversion of Notes Payable Warrants upon Merger

$

 

 

$

4,576

 

Public Warrants and Private Placement Warrants acquired in Merger

$

 

 

$

50,850

 

Issuance of conversion option

$

 

 

$

8,783

 

Purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities

$

3,058

 

 

$

3,578

 

Purchases of inventory included in accounts payable and accrued expenses and other current liabilities

$

1,553

 

 

$

1,854

 

Financing leases

$

806

 

 

$

46,021

 
 

Benson Hill, Inc.
Non-GAAP Reconciliation
(Dollar Amounts in Thousands)

This press release contains financial measures not derived in accordance with generally accepted accounting principles ("GAAP"). Reconciliations to the most comparable GAAP measures are provided below. The Company defines Adjusted EBITDA as net loss from continuing operations excluding income taxes, interest, depreciation, amortization, stock-based compensation, and the impact of significant non-recurring items.

Adjustments to reconcile net loss from our continuing operations to Adjusted EBITDA for the years ended December 31, 2022 and 2021 are as follows:

 

 

Three Months Ended December 31,

 

Year Ended December 31,

(in thousands)

 

2022
(unaudited)

 

2021
(unaudited)

 

2022
(unaudited)

 

2021
(unaudited)

Adjustments to reconcile net loss from continuing operations to Adjusted EBITDA

Net loss from continuing operations

 

$

(30,763

)

 

$

(41,193

)

 

$

(99,700

)

 

$

(122,200

)

Interest expense, net

 

 

5,414

 

 

 

611

 

 

 

21,444

 

 

 

4,481

 

Income tax expense (benefit)

 

 

29

 

 

 

13

 

 

 

59

 

 

 

231

 

Depreciation and amortization

 

 

5,909

 

 

 

3,444

 

 

 

20,513

 

 

 

10,478

 

Stock-based compensation

 

 

3,749

 

 

 

4,414

 

 

 

19,520

 

 

 

7,183

 

Change in fair value of warrants

 

 

(7,389

)

 

 

398

 

 

 

(49,063

)

 

 

(12,127

)

Other non-recurring costs, including acquisitions

 

 

1,619

 

 

 

3,193

 

 

 

5,582

 

 

 

4,688

 

Employee retention credit

 

 

 

 

 

 

 

 

 

 

 

(1,550

)

Merger transaction costs

 

 

 

 

 

 

 

 

 

 

 

11,693

 

Non-recurring public company readiness costs

 

 

 

 

 

 

 

 

 

 

 

5,265

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

 

11,742

 

South America seed production costs

 

 

 

 

 

 

 

 

 

 

 

2,805

 

Adjusted EBITDA

 

$

(21,432

)

 

$

(29,120

)

 

$

(81,645

)

 

$

(77,311

)

Adjustments to reconcile estimated 2023 net loss from continuing operations to estimated Adjusted EBITDA are as follows:

 

2023 Estimate

Net loss from continuing operations

$

(125,000

)

-

(135,000

)

Interest expense, net

 

27,000

 

-

29,000

 

Depreciation and amortization

 

21,000

 

-

23,000

 

Stock-based compensation

 

14,000

 

-

15,000

 

Total Adjusted EBITDA

$

(63,000

)

-

(68,000

)

 

Benson Hill, Inc.
Supplemental Schedules – 2023 Free Cash Flow Non-GAAP Reconciliation
(Dollar Amounts in Thousands)

 

Adjustments to reconcile estimated free cash flow:

 

 

2023 Estimate

Net loss from continuing operations

$ (125,000) – (135,000)

Depreciation and amortization

21,000 – 23,000

Stock-based compensation

14,000 – 15,000

Changes in working capital

(12,000) – (14,000)

Other

2,000 – 8,000

Net Cash Used on Operating Activities

$ (100,000) – (103,000)

Payments for acquisition of property and equipment

(20,000) – (25,000)

Free Cash Flow

$ (120,000) – (128,000)

 

Investors: Ruben Mella: (314) 714-6313 / rmella@bensonhill.com

Media: Christi Dixon: (636) 359-0797 / cdixon@bensonhill.com

Source: Benson Hill, Inc.

FAQ

What are Benson Hill's 2023 revenue projections?

Benson Hill expects its proprietary revenues to reach between $100 million and $110 million in 2023.

What was Benson Hill's revenue for 2022?

In 2022, Benson Hill reported revenues of $381 million, a 319% increase compared to the previous year.

What is the expected net loss for Benson Hill in 2023?

Benson Hill anticipates a net loss of $125 million to $135 million for 2023.

What is Benson Hill's goal for Adjusted EBITDA by 2025?

Benson Hill aims to achieve positive Adjusted EBITDA by 2025.

How did Benson Hill's proprietary revenues perform in 2022?

Proprietary revenues nearly doubled in 2022, reaching $73 million.

Benson Hill, Inc.

NASDAQ:BHIL

BHIL Rankings

BHIL Latest News

BHIL Stock Data

25.19M
3.66M
40.11%
18.18%
1.56%
Agricultural Inputs
Food and Kindred Products
Link
United States of America
ST. LOUIS